Immune Checkpoint Inhibitor–Related Myocarditis With or Without Concomitant Myopathy
Patients with irMyocarditis and irMyopathy and those with isolated irMyocarditis have distinct biomarker profiles and cardiovascular complications. These differences should be confirmed in larger prospective cohorts to guide tailored management strategies.
Authors
- Anju Nohria (ORCID: https://orcid.org/0000-0002-7113-1118)
- Osnat Itzhaki Ben Zadok
- Méabh O’Hare (ORCID: https://orcid.org/0000-0002-9577-6383)
Institutions
- Brigham and Women's Hospital (US)
- Tel Aviv University (IL)
Publication Details
- Journal
- JACC CardioOncology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1016/j.jaccao.2025.02.005
- Citations
- 7
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 7.32